BBNX logo

Beta Bionics, Inc. (BBNX) EBITDA

Annual EBITDA:

-$42.97M-$9.21M(-27.28%)
December 31, 2024

Summary

  • As of today, BBNX annual EBITDA is -$42.97 million, with the most recent change of -$9.21 million (-27.28%) on December 31, 2024.
  • During the last 3 years, BBNX annual EBITDA has risen by +$19.68 million (+31.42%).
  • BBNX annual EBITDA is now -27.28% below its all-time high of -$33.76 million, reached on December 31, 2023.

Performance

1-Year Change

-27.28%

3-Year Change

+31.42%

5-Year Change

+31.42%

15-Year Change

+31.42%

BBNX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

33.39%
BBNX annual EBITDA is higher than 33.39% of companies in Healthcare sector

Range

All-Time High

-$33.76M
BBNX annual EBITDA is currently -27.28% below its historical high of -$33.76 million

3-Year Low

-$62.65M
BBNX annual EBITDA is currently +31.42% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBNX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 24, 2026
BBNX next annual earnings announcement is scheduled for Mar 24, 2026

OtherBBNXincome statement metrics

Annual Revenue

$65.12M
BBNX annual revenue is $65.12 million

Annual Net Income

-$54.76M
BBNX annual net profit is -$54.76 million

Annual EBIT

-$45.25M
BBNX annual earnings before interest & taxes is -$45.25 million

Annual EPS

-$1.26
BBNX annual earnings per share is -$1.26

Quarterly EBITDA:

-$16.36M+$2.86M(+14.88%)
September 30, 2025

Summary

  • As of today, BBNX quarterly EBITDA is -$16.36 million, with the most recent change of +$2.86 million (+14.88%) on September 30, 2025.
  • Over the past year, BBNX quarterly EBITDA has dropped by -$6.00 million (-57.88%).
  • BBNX quarterly EBITDA is now -126.12% below its all-time high of -$7.24 million, reached on September 30, 2023.

Performance

3-Month Change

+14.88%

1-Year Change

-57.88%

3-Year Change

-126.12%

5-Year Change

-126.12%

BBNX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

24.36%
BBNX quarterly EBITDA is higher than 24.36% of companies in Healthcare sector

Range

All-Time High

-$7.24M
BBNX quarterly EBITDA is currently -126.12% below its historical high of -$7.24 million

3-Year Low

-$19.22M
BBNX quarterly EBITDA is currently +14.88% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBNX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
BBNX next earnings announcement is scheduled for Mar 24, 2026

OtherBBNXincome statement metrics

Quarterly Revenue

$27.25M
BBNX quarterly revenue is $27.25 million

Quarterly Net Income

-$14.21M
BBNX quarterly net profit is -$14.21 million

Quarterly EBIT

-$17.04M
BBNX quarterly earnings before interest & taxes is -$17.04 million

Quarterly EPS

-$0.33
BBNX quarterly earnings per share is -$0.33

TTM EBITDA:

-$66.13M-$6.00M(-9.98%)
September 30, 2025

Summary

  • As of today, BBNX TTM EBITDA is -$66.13 million, with the most recent change of -$6.00 million (-9.98%) on September 30, 2025.
  • Over the past year, BBNX TTM EBITDA has dropped by -$27.84 million (-72.73%).
  • BBNX TTM EBITDA is now -813.96% below its all-time high of -$7.24 million, reached on September 30, 2023.

Performance

3-Month Change

-9.98%

1-Year Change

-72.73%

3-Year Change

-813.96%

5-Year Change

-813.96%

BBNX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

23.91%
BBNX TTM EBITDA is higher than 23.91% of companies in Healthcare sector

Range

All-Time High

-$7.24M
BBNX TTM EBITDA is currently -813.96% below its historical high of -$7.24 million

3-Year Low

-$66.13M
BBNX TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBNX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
BBNX next earnings announcement is scheduled for Mar 24, 2026

OtherBBNXincome statement metrics

TTM Revenue

$88.57M
BBNX TTM revenue is $88.57 million

TTM Net Income

-$77.84M
BBNX TTM net profit is -$77.84 million

TTM EBIT

-$68.59M
BBNX TTM earnings before interest & taxes is -$68.59 million

TTM EPS

-$1.79
BBNX TTM earnings per share is -$1.79

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$42.97M
BBNX annual EBITDA is -$42.97 million

Annual Net Income

-$54.76M
BBNX annual net profit is -$54.76 million

Annual Interest Expense

$0.00
BBNX annual interest expense is $0.00

Annual Income Tax

$0.00
BBNX annual income tax is $0.00

Annual D&A

$2.28M
BBNX annual D&A is $2.28 million

BBNX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-27.3%-57.9%-72.7%
3Y3 Years+31.4%-126.1%-814.0%
5Y5 Years+31.4%-126.1%-814.0%

BBNX EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-27.3%+31.4%-126.1%+14.9%-814.0%at low
5Y5-Year-27.3%+31.4%-126.1%+14.9%-814.0%at low
All-TimeAll-Time-27.3%+31.4%-126.1%+14.9%-814.0%at low

BBNX EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$16.36M(+14.9%)
-$66.13M(-10.0%)
Jun 2025
-
-$19.22M(-6.5%)
-$60.13M(-15.4%)
Mar 2025
-
-$18.04M(-44.2%)
-$52.12M(-21.3%)
Dec 2024
-$42.97M
-$12.51M(-20.7%)
-$42.97M(-12.2%)
Sep 2024
-
-$10.36M(+7.5%)
-$38.28M(-8.9%)
DateAnnualQuarterlyTTM
Jun 2024
-
-$11.21M(-26.1%)
-$35.16M(-46.8%)
Mar 2024
-
-$8.89M(-13.6%)
-$23.95M(-59.0%)
Dec 2023
-$33.76M(+46.1%)
-$7.82M(-8.1%)
-$15.06M(-108.1%)
Sep 2023
-
-$7.24M
-$7.24M
Dec 2022
-$62.65M
-
-

FAQ

  • What is Beta Bionics, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual EBITDA year-on-year change?
  • What is Beta Bionics, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly EBITDA year-on-year change?
  • What is Beta Bionics, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. TTM EBITDA year-on-year change?

What is Beta Bionics, Inc. annual EBITDA?

The current annual EBITDA of BBNX is -$42.97M

What is the all-time high annual EBITDA for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual EBITDA is -$33.76M

What is Beta Bionics, Inc. annual EBITDA year-on-year change?

Over the past year, BBNX annual EBITDA has changed by -$9.21M (-27.28%)

What is Beta Bionics, Inc. quarterly EBITDA?

The current quarterly EBITDA of BBNX is -$16.36M

What is the all-time high quarterly EBITDA for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly EBITDA is -$7.24M

What is Beta Bionics, Inc. quarterly EBITDA year-on-year change?

Over the past year, BBNX quarterly EBITDA has changed by -$6.00M (-57.88%)

What is Beta Bionics, Inc. TTM EBITDA?

The current TTM EBITDA of BBNX is -$66.13M

What is the all-time high TTM EBITDA for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high TTM EBITDA is -$7.24M

What is Beta Bionics, Inc. TTM EBITDA year-on-year change?

Over the past year, BBNX TTM EBITDA has changed by -$27.84M (-72.73%)
On this page